Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review

Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Heron Therapeutics Inc (Heron) is a biotechnology company that uses proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from various types of cancer and pain. Its proprietary Biochronomer technology is a polymer-based drug delivery platform, that improves the therapeutic profile of injectable pharmaceuticals. The company's marketed products include Sustol, an extended-release injection indicated in combination with other antiemetics in adults for the prevention of nausea and vomiting due to moderately emetogenic chemotherapy (MEC); Cinvanti for chemotherapy-induced nausea and vomiting (CINV) prevention; Aponvie for the prevention of postoperative nausea and vomiting (PONV) in adults; and Zynrelef (HTX-011) for the treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults. Heron is headquartered in San Diego, California, the US.

Heron Therapeutics Inc Key Recent Developments

Apr 11,2024: Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Mar 18,2024: Heron Therapeutic Announces Appointment of Principal Accounting Officer
Jul 24,2023: Heron Therapeutics Announces Cost Reduction Plan and Restructuring
Jul 12,2023: Heron Therapeutics : Kimberly Manhard resigned as Executive Vice President

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Heron Therapeutics Inc - Key Facts
Heron Therapeutics Inc - Key Employees
Heron Therapeutics Inc - Key Employee Biographies
Heron Therapeutics Inc - Major Products and Services
Heron Therapeutics Inc - History
Heron Therapeutics Inc - Company Statement
Heron Therapeutics Inc - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Heron Therapeutics Inc - Business Description
R&D Overview
Heron Therapeutics Inc - Corporate Strategy
Heron Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Heron Therapeutics Inc - Strengths
Heron Therapeutics Inc - Weaknesses
Heron Therapeutics Inc - Opportunities
Heron Therapeutics Inc - Threats
Heron Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Heron Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 11, 2024: Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Mar 18, 2024: Heron Therapeutic Announces Appointment of Principal Accounting Officer
Jul 24, 2023: Heron Therapeutics Announces Cost Reduction Plan and Restructuring
Jul 12, 2023: Heron Therapeutics : Kimberly Manhard resigned as Executive Vice President
Jun 23, 2023: Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
Jun 12, 2023: Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
May 11, 2023: Heron Therapeutics announces financial results for the three months ended March 31, 2023 and highlights recent corporate updates
Apr 20, 2023: Heron Therapeutics Announces Commercial Leadership Changes
Apr 03, 2023: Heron Therapeutics Announces New CEO and Board Chairman
Mar 23, 2023: Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Heron Therapeutics Inc, Key Facts
Heron Therapeutics Inc, Key Employees
Heron Therapeutics Inc, Key Employee Biographies
Heron Therapeutics Inc, Major Products and Services
Heron Therapeutics Inc, History
Heron Therapeutics Inc, Key Competitors
Heron Therapeutics Inc, Ratios based on current share price
Heron Therapeutics Inc, Annual Ratios
Heron Therapeutics Inc, Annual Ratios (Cont...1)
Heron Therapeutics Inc, Annual Ratios (Cont...2)
Heron Therapeutics Inc, Interim Ratios
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Heron Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Heron Therapeutics Inc, Performance Chart (2019 - 2023)
Heron Therapeutics Inc, Ratio Charts
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings